Internal Med

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Holmes DR et al. – A JACC white paper reports that it is both prudent and timely to review treatment strategies using combinations of antiplatelet and anticoagulant therapies as well as strategies aimed at reducing bleeding risk in pts treated with these therapies.

Methods

Results

Related Articles

The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy
Blood, 11/24/09    Relevance Score: 79%%

Perioperative management of warfarin and antiplatelet therapy
Cleveland Clinic Journal of Medicine, 12/02/09    Relevance Score: 70%%

Dual antiplatelet therapy in coronary artery disease: A case-based approach
Cleveland Clinic Journal of Medicine, 11/04/09    Relevance Score: 69%%

Subretinal Hemorrhages Associated with Age-Related Macular Degeneration in Patients Receiving Anticoagulation or Antiplatelet Therapy
American Journal of Ophthalmology, 11/25/09    Relevance Score: 67%%

Pharmaco-active stents
Sang Thrombose Vaisseaux, 11/04/09    Relevance Score: 66%%

Today in Vascular Medicine...keeping you current

Ability of Physical Activity to Predict Cardiovascular Disease Beyond Commonly Evaluated Cardiometabolic Risk Factors
The American Journal of Cardiology, 12/02/09

Natural History of Syphilitic Aortitis
The American Journal of Cardiology, 12/02/09

Mismatch-Based Delayed Thrombolysis. A Meta-Analysis
Stroke, 12/02/09